Natco Pharma Approves Rights Issue of ₹1,279 Cr

Natco Pharma Limited's Board of Directors, in a meeting held on September 25, 2026, approved a rights issue of equity shares amounting to ₹1,279.36 crore. The issue will offer 17,058,082 equity shares at a price of ₹750 per share, including a premium of ₹748. The rights entitlement ratio is 2 equity shares for every 21 held as of the record date, October 1, 2026. The rights issue will open on October 12, 2026, and close on October 22, 2026. The company's outstanding equity shares will increase from 179,109,870 to 196,167,952 assuming full subscription.